Literature DB >> 24036190

Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats.

Youhua Zhang1, Eduard I Dedkov, Diana Teplitsky, Nathan Y Weltman, Christine J Pol, Viswanathan Rajagopalan, Bianca Lee, A Martin Gerdes.   

Abstract

BACKGROUND: Evidence indicates that cardiac hypothyroidism may contribute to heart failure progression. It is also known that heart failure is associated with an increased risk of atrial fibrillation (AF). Although it is established that hyperthyroidism increases AF incidence, the effect of hypothyroidism on AF is unclear. This study investigated the effects of different thyroid hormone levels, ranging from hypothyroidism to hyperthyroidism on AF inducibility in thyroidectomized rats. METHODS AND
RESULTS: Thyroidectomized rats with serum-confirmed hypothyroidism 1 month after surgery were randomized into hypothyroid (N=9), euthyroid (N=9), and hyperthyroid (N=9) groups. Rats received placebo, 3.3-mg l-thyroxine (T4), or 20-mg T4 pellets (60-day release form) for 2 months, respectively. At the end of treatment, hypothyroid, euthyroid, and hyperthyroid status was confirmed. Hypothyroid animals showed cardiac atrophy and reduced cardiac systolic and diastolic functions, whereas hyperthyroid rats exhibited cardiac hypertrophy and increased cardiac function. Hypothyroidism and hyperthyroidism produced opposite electrophysiological changes in heart rates and atrial effective refractory period, but both significantly increased AF susceptibility. AF incidence was 78% in hypothyroid, 67% in hyperthyroid, and the duration of induced AF was also longer, compared with 11% in the euthyroid group (all P<0.05). Hypothyroidism increased atrial interstitial fibrosis, but connexin 43 was not affected.
CONCLUSIONS: Both hypothyroidism and hyperthyroidism lead to increased AF vulnerability in a rat thyroidectomy model. Our results stress that normal thyroid hormone levels are required to maintain normal cardiac electrophysiology and to prevent cardiac arrhythmias and AF.

Entities:  

Keywords:  arrhythmias, cardiac; atrial fibrillation; electrophysiology; thyroid hormones

Mesh:

Substances:

Year:  2013        PMID: 24036190      PMCID: PMC3973490          DOI: 10.1161/CIRCEP.113.000502

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  32 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

3.  Atrial electrophysiology in experimental hyperthyroidism in rabbits.

Authors:  M F Arnsdorf; R W Childers
Journal:  Circ Res       Date:  1970-05       Impact factor: 17.367

4.  Masked thyroid dysfunction in elderly patients with atrial fibrillation.

Authors:  J Tajiri; M Morita; K Higashi; T Sato
Journal:  Arch Intern Med       Date:  1985-06

5.  Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes.

Authors:  Yao-Chang Chen; Shih-Ann Chen; Yi-Jen Chen; Mau-Song Chang; Paul Chan; Cheng-I Lin
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

6.  Single-channel activity and expression of atrial L-type Ca(2+) channels in patients with latent hyperthyroidism.

Authors:  U Kreuzberg; P Theissen; H Schicha; F Schröder; U Mehlhorn; E R de Vivie; P Bokník; J Neumann; C Grohé; S Herzig
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-03       Impact factor: 4.733

7.  Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease.

Authors:  Giorgio Iervasi; Alessandro Pingitore; Patrizia Landi; Mauro Raciti; Andrea Ripoli; Maria Scarlattini; Antonio L'Abbate; Luigi Donato
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

8.  Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium.

Authors:  Hiroshi Watanabe; Meilei Ma; Takashi Washizuka; Satoru Komura; Tsuyoshi Yoshida; Yukio Hosaka; Katsuharu Hatada; Masaomi Chinushi; Tadashi Yamamoto; Kenichi Watanabe; Yoshifusa Aizawa
Journal:  Biochem Biophys Res Commun       Date:  2003-08-29       Impact factor: 3.575

9.  The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium.

Authors:  J L Smeets; M A Allessie; W J Lammers; F I Bonke; J Hollen
Journal:  Circ Res       Date:  1986-01       Impact factor: 17.367

10.  Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats.

Authors:  Yue-Feng Chen; Nathan Y Weltman; Xiang Li; Steven Youmans; David Krause; Anthony Martin Gerdes
Journal:  J Transl Med       Date:  2013-02-14       Impact factor: 5.531

View more
  36 in total

1.  Alterations in atrial ion channels and tissue structure promote atrial fibrillation in hypothyroid rats.

Authors:  Jianqiang Li; Zhaorui Liu; Hongwei Zhao; Fengxiang Yun; Zhaoguang Liang; Dingyu Wang; Xinbo Zhao; Jiawei Zhang; Hai Cang; Yilun Zou; Yue Li
Journal:  Endocrine       Date:  2019-06-07       Impact factor: 3.633

Review 2.  Role of thyroid hormones in ventricular remodeling.

Authors:  Viswanathan Rajagopalan; A Martin Gerdes
Journal:  Curr Heart Fail Rep       Date:  2015-04

3.  Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses.

Authors:  Elvira Alonso-Merino; Rosa Martín Orozco; Lidia Ruíz-Llorente; Olaia A Martínez-Iglesias; Juan Pedro Velasco-Martín; Ana Montero-Pedrazuela; Luisa Fanjul-Rodríguez; Constanza Contreras-Jurado; Javier Regadera; Ana Aranda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

4.  Derivation of a measure of physiological multisystem dysregulation: Results from WHAS and health ABC.

Authors:  Alden L Gross; Michelle C Carlson; Nadia M Chu; Mara A McAdams-DeMarco; Dan Mungas; Eleanor M Simonsick; Ravi Varadhan; Qian-Li Xue; Jeremy Walston; Karen Bandeen-Roche
Journal:  Mech Ageing Dev       Date:  2020-05-11       Impact factor: 5.432

5.  Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy.

Authors:  Kuo Zhang; Wenyao Wang; Shihua Zhao; Stuart D Katz; Giorgio Iervasi; A Martin Gerdes; Yi-Da Tang
Journal:  Clin Cardiol       Date:  2018-01-23       Impact factor: 2.882

Review 6.  Thyroid Dysfunction and Heart Failure: Mechanisms and Associations.

Authors:  Hernando Vargas-Uricoechea; Anilza Bonelo-Perdomo
Journal:  Curr Heart Fail Rep       Date:  2017-02

7.  Long-term physiological T3 supplementation in hypertensive heart disease in rats.

Authors:  Nathan Y Weltman; Christine J Pol; Youhua Zhang; Yibo Wang; Adrienne Koder; Sarah Raza; Riccardo Zucchi; Alessandro Saba; Daria Colligiani; A Martin Gerdes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

8.  U-shaped association between serum free triiodothyronine and recurrence of atrial fibrillation after catheter ablation.

Authors:  Shao-Bin Wei; Wei Wang; Nian Liu; Ji Chen; Xue-Yuan Guo; Ri-Bo Tang; Rong-Hui Yu; De-Yong Long; Cai-Hua Sang; Chen-Xi Jiang; Song-Nan Li; Song-Nan Wen; Jia-Hui Wu; Rong Bai; Xin Du; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  J Interv Card Electrophysiol       Date:  2018-02-26       Impact factor: 1.900

9.  Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model.

Authors:  Youhua Zhang; Eduard I Dedkov; Bianca Lee; Ying Li; Khusbu Pun; A Martin Gerdes
Journal:  J Card Fail       Date:  2014-11-25       Impact factor: 5.712

10.  HYPOTHYROIDISM INCREASES EXPRESSION OF STERILE INFLAMMATION PROTEINS IN RAT HEART TISSUE.

Authors:  E Sahin; E Bektur; C Baycu; D Burukoglu Dönmez; B Kaygısız
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.